Skip to main content

Pediatric Low-Grade Gliomas: Diagnosis, Treatment, and Future Directions

  • Chapter
Book cover Tumors of the Central Nervous System, Volume 14

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 14))

Abstract

Low-grade gliomas are the most common brain tumor in children, accounting for 30–50% of central nervous system tumors in the pediatric age group. They can arise anywhere along the neuraxis and are a heterogeneous group of neoplasms with treatments and outcomes that vary widely by age, tumor location, and extent of surgical resection. Treatment ranges from expectant observation to surgery, chemotherapy, and radiotherapy as single or combined modality therapies. Pediatric low-grade gliomas share a unique association with several inherited genetic conditions, including neurofibromatosis type 1 and tuberous sclerosis. Children with these genetic disorders have a markedly increased risk of developing low-grade gliomas during childhood, and the prognosis and treatment choices may differ substantially from children with identical tumors who do not carry these genetic mutations. Long-term overall survival of all children with low-grade gliomas is very good; therefore, the potential late effects of treatment must be considered carefully in making treatment decisions. As our understanding of the genetic aberrations in low-grade gliomas evolves, novel molecular targets are being identified that may allow for more precise, tumor-directed drug delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ater J, Holmes E, Zhou H (2008) Abstracts from the thirteenth international symposium on pediatric neuro-oncology: results of COG protocol A9952- a randomized phase 3 study of two chemotherapy regimens for incompletely resected low-grade glioma in young children. Neuro Oncol 10:451

    Google Scholar 

  • Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff HH, Pollack IF (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol 30:264–267

    Article  Google Scholar 

  • Banerjee S, Crouse NR, Emnett RJ, Gianino SM, Gutmann DH (2011) Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner. Proc Natl Acad Sci U S A 108:15996–16001

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30:1358–1363

    Article  CAS  PubMed  Google Scholar 

  • Brower JV, Indelicato DJ, Aldana PR, Sandler E, Rotondo R, Mendenhall NP, Marcus RB, Su Z (2013) A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas. Acta Oncol 52:594–599

    Article  PubMed Central  PubMed  Google Scholar 

  • Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(suppl 5):v1–v49

    Article  PubMed Central  PubMed  Google Scholar 

  • Fisher MJ, Phillips PC (2006) PET Imaging of brain tumors. In: Charron M (ed) Practical pediatric PET imaging. Springer, New York, pp 175–219

    Google Scholar 

  • Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L (2001) Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 51:704–710

    Article  CAS  PubMed  Google Scholar 

  • Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14:790–797

    Article  PubMed Central  PubMed  Google Scholar 

  • Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL (2003) Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children’s Cancer Group high-grade glioma study CCG-945. Cancer 98:1243–1252

    Article  PubMed  Google Scholar 

  • Franz EN, Weiss BD (2012) Molecular therapies for tubersous sclerosis and neurofibromatosis. Curr Neurol Neurosci Rep 12:294–301

    Article  CAS  PubMed  Google Scholar 

  • Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittlemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381:125–132

    Article  CAS  PubMed  Google Scholar 

  • Gilles FH, Tavare CJ, Becker LE, Burger PC, Yates AJ, Pollack IF, Finlay JL (2008) Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatr Dev Pathol 11:108–117

    Article  PubMed  Google Scholar 

  • Gururangan S, Fisher MJ, Allen JC, Herndon JE, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, Phillips PC, Watral MA, Krauser JM, Friedman AH, Friedman HS (2007) Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9:161–168

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S (2010) RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464:431–435

    Article  CAS  PubMed  Google Scholar 

  • Heidorn SJ, Milagre C, Whittaker S, Nourry A, Niculescu-Duvas I, Dhomen N, Hussain J, Reis-Filho JS, Springer CJ, Pritchard C, Marais R (2010) Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140:209–221

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G, Rood BR, Packer RJ (2012) Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer 60:776–782

    Article  PubMed  Google Scholar 

  • Johnson MW, Eberhart CG, Perry A, Tihan T, Cohen KJ, Rosenblum MK, Rais-Bahrami S, Goldthwaite P, Burger PC (2010) Spectrum of pilomyxoid astrocytoma: intermediate pilomyxoid tumors. Am J Surg Pathol 34:1783–1791

    Article  PubMed  Google Scholar 

  • Jones DT, Hutter B…(75 total authors), Pfister SM (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45: 927–932

    Google Scholar 

  • Kortmann R, Pietsch T, Warmuth-Metz M, Gnekow A (2010) SIOP HIT-LGG 2004: Radiotherapy for children with low-grade glioma, an international multicentre trial, interim analysis for German patients. Neuro Oncol 12:ii18

    Google Scholar 

  • Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C (2003) Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy–results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572–4578

    Article  CAS  PubMed  Google Scholar 

  • Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209–4216

    Article  CAS  PubMed  Google Scholar 

  • Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA, Catania S, Sardi I, Giangaspero F (2010) A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol 100:65–71

    Article  CAS  PubMed  Google Scholar 

  • Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA (2010) Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol 100:121–127

    Article  PubMed Central  PubMed  Google Scholar 

  • Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L (1988) Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 23:79–85

    Article  CAS  PubMed  Google Scholar 

  • Packer RJ, Ater J, Allen J, Phillips PC, Geyer R, Nicholson HS, Jakacki R, Kurcynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747–754

    Article  CAS  PubMed  Google Scholar 

  • Perilongo G, Garre ML, Giangaspero F (2003) Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 19:197–203

    PubMed  Google Scholar 

  • Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739–1749

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA (1997) Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32:235–341

    Article  CAS  PubMed  Google Scholar 

  • Puget S, Crimmins DW, Garnett MR, Grill J, Oliverira R, Boddaert N, Wray A, Lelouch-Tubiana A, Roujeau T, Di Rocco F, Zerah M, Sainte-Rose C (2007) Thalamic tumors in children: a reappraisal. J Neurosurg 106:354–362

    PubMed  Google Scholar 

  • Reimers TS, Mortensen EL, Schmiegelow K (2007) Memory deficits in long-term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions. Pediatr Blood Cancer 48:205–212

    Article  PubMed  Google Scholar 

  • Ris MD, Beebe DW, Armstrong FD, Fontanesi J, Holmes E, Sanford RA, Wisoff JH (2008) Cognitive and adaptive outcome in extracerebellar low-grade brain tumors in children: a report from the Children’s Oncology Group. J Clin Oncol 26:4765–4670

    Article  PubMed Central  PubMed  Google Scholar 

  • Rutka JT, Kuo JS (2004) Pediatric surgical neuro-oncology: current best care practices and strategies. J Neurooncol 69:139–150

    Article  PubMed  Google Scholar 

  • Salama AK, Flaherty KT (2013) BRAF in melanoma: current strategies and future directions. Clin Cancer Res 19:4326–4334

    Article  CAS  PubMed  Google Scholar 

  • Scheinemann K, Bartels U, Huang A, Hawkins C, Kulkarni AV, Bouffet E, Tabori U (2009) Survival and functional outcome of childhood spinal cord low-grade gliomas. J Neurosurg Pediatr 4:254–261

    Article  PubMed  Google Scholar 

  • Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol 5:153–160

    Article  PubMed Central  PubMed  Google Scholar 

  • Sievert AJ, Fisher MJ (2009) Pediatric low-grade gliomas. J Child Neurol 24:1397–1408

    Article  PubMed Central  PubMed  Google Scholar 

  • Sievert AJ, Jackson EM, Gai X, Hakonarson H, Judkins AR, Resnick AC, Sutton LN, Storm PB, Shaikh TH, Biegel JA (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 19:449–58

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sievert AJ, Lang S-S, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC (2013) Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proc Natl Acad Sci U S A 110:5957–5962

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang J, Wu G…(48 total authors), Ellison DW (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45: 602–612

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael J. Fisher .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Waanders, A.J., Minturn, J.E., Fisher, M.J. (2015). Pediatric Low-Grade Gliomas: Diagnosis, Treatment, and Future Directions. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 14. Tumors of the Central Nervous System, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7224-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7224-2_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7223-5

  • Online ISBN: 978-94-017-7224-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics